Genmab A/S
CSE:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
CSE:GMAB
Watchlist
Price: 1 477.5 DKK -1.17%
Market Cap: 94.7B DKK

P/OCF
Price to OCF

-1 728.9
Current
39.8
Median
19.4
Industry
Lower than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-1 728.9
=
Market Cap
94.7B DKK
/
Operating Cash Flow
-54.2m DKK
 
DK
Genmab A/S
CSE:GMAB
Average P/OCF: 17.3
Negative Multiple: -1 728.9
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -218 048
US
Abbvie Inc
NYSE:ABBV
20.4
US
Amgen Inc
NASDAQ:AMGN
12.9
US
Gilead Sciences Inc
NASDAQ:GILD
13.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -118.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -515.9
AU
CSL Ltd
ASX:CSL
25.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
14.3
US
S
Seagen Inc
F:SGT
Negative Multiple: -83.3
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -873.7

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A